Search results for: Health Policy and Regulation
Filter search results
One Europe, one assessment? Unpacking the European Joint Clinical Assessment
28 May 2026
…Health Technology Assessment; HTD, health technology developer; JCA, Joint Clinical Assessments; JSC, Joint Scientific Consultation; NOMA, Norwegian Medical Products Agency; P&R, pricing and reimbursement; TLV, Dental and Pharmaceutical Benefits Agency Current and Emerging Challenges Implementation of…
Around the World in HTAs: Kenya – Riding the Waves of Change
19 May 2025
…in healthcare, evaluating healthcare interventions, and guiding healthcare decision-making processes. As new health technologies and interventions, including therapies, digital health technologies and innovative diagnostics, continue to emerge, Kenya has made…
Germany’s drug-pricing dilemma: Why Europe’s pivotal market holds the key to the MFN debate
25 June 2026
…States; it is between national affordability objectives and global innovation incentives, and it is visible across Europe. Governments want innovative medicines, thriving life-sciences sectors, investment and jobs and to lower…
Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly
18 July 2022
…A., Cubi-Molla, P. and Jofre-Bonet, M., 2022. Discontinuation of Performance-Based Financing in Primary Health Care: Impact on Family Planning and Maternal and Child Health. International Journal of Health Economics and…
New research highlights mounting pressure on NHS immunoglobulin supply
8 October 2026
…resources, research and analyses in health economics, health policy and health statistics. Our work informs decision–making about health care and pharmaceutical issues at a global level. All of our work is…
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
14 October 2025
…needs improved population health, sustained productivity improvements in the NHS and the scale and spread of cost-effective innovation. She pointed out that the policy directions in the 10 Year Health…
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
20 October 2025
…in health economics, health policy and health statistics. Our work informs decision–making about health care and pharmaceutical issues at a global level. All of our work is available for free…
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…systems and patients: price increases for the drug in shortage as well as substitute products, additional healthcare resource use, and patient health impact. For health systems, increase in demand for…
Around The World in HTAs: The Netherlands – 5 Routes for New Tech
24 May 2023
…Netherlands, Luxembourg, Austria and Ireland is the BeNeLuxA initiative, which aims to improve collaboration on pharmaceutical policy and procurement by means of horizon scanning, HTA, information sharing and policy exchange,…